| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $47.4M | -62.7% |
| Cost of Revenue | $59.9M | -49.5% |
| Gross Profit | -$12.6M | -251.6% |
| R&D Expense | $5.9M | -17.5% |
| SG&A Expense | $25.4M | -31.4% |
| Operating Income | -$52.8M | -4.0% |
| Interest Expense | -$665K | +48.2% |
| Pre-tax Income | -$48.4M | +4.4% |
| Income Tax | $230K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.2M | -55.4% |
| Accounts Receivable | $39.7M | -39.2% |
| Inventory | $10.1M | +159.8% |
| Current Assets | $76.1M | -29.8% |
| Total Assets | $89.9M | -26.9% |
| Current Liabilities | $49.1M | -10.2% |
| Long-term Debt | $9.5M | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.7M | +34.1% |
| Capital Expenditures | $1.6M | +101.6% |
| Investing Cash Flow | $6.3M | +1677.3% |
| Financing Cash Flow | $14.5M | -57.3% |
| Free Cash Flow | -$36.3M | +32.0% |
| +168.0% |
| Net Income | -$48.6M | +3.3% |
| EPS (Basic) | -$3.83 | -770.5% |
| EPS (Diluted) | -$3.83 | -770.5% |
| Total Liabilities |
| $70.9M |
| +17.0% |
| Stockholders' Equity | $19.0M | -69.5% |